公开(公告)号：EP2094261A1

公开(公告)日：2009-09-02

申请号：EP07834303.5

申请日：2007-11-26

申请人： Mazence Inc. ,  KT & G Co., Ltd.

发明人： JO, In Geun ,  YOO, Sang-Ku ,  PARK, Myung-gyu ,  KWAK, Taehwan

IPC分类号： A61K31/33 ,  A61K31/453 ,  A61K9/32 ,  A61P3/10 ,  A61P3/04

CPC分类号： A61K31/34 ,  A61K9/145

摘要： Provided is an oral pharmaceutical composition with improved bioavailability and pharmacokinetic properties of a drug, by increasing a bioabsorption rate and an in vivo retention time of an active ingredient via intestine-targeted formulation of a particular naphthoquinone-based compound, or a pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, as an active ingredient.